Cargando…

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

Numerous studies have tested the association between TP53 mutations in ovarian cancer and prognosis but these have been consistently confounded by limitations in study design, methodology, and/or heterogeneity in the sample cohort. High-grade serous (HGS) carcinoma is the most clinically important h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Ahmed Ashour, Etemadmoghadam, Dariush, Temple, Jillian, Lynch, Andy G, Riad, Mohamed, Sharma, Raghwa, Stewart, Colin, Fereday, Sian, Caldas, Carlos, deFazio, Anna, Bowtell, David, Brenton, James D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd. 2010
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262968/ https://www.ncbi.nlm.nih.gov/pubmed/20229506 http://dx.doi.org/10.1002/path.2696

Ejemplares similares

High resolution melting for mutation scanning of TP53 exons 5–8
por: Krypuy, Michael, et al.
Publicado: (2007)

High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival
por: Baumbusch, Lars O., et al.
Publicado: (2013)

Benign serous ovarian tumour: a redefining moment?
por: Hunter, Sally, et al.
Publicado: (2012)

Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
por: Christie, Elizabeth L., et al.
Publicado: (2019)

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
por: Hunter, Sally M., et al.
Publicado: (2015)

Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis
por: Emmanuel, Catherine, et al.
Publicado: (2011)

Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
por: Helland, Åslaug, et al.
Publicado: (2011)

Primary treatment patterns in women recruited to the Australian Ovarian Cancer Study
por: Hung, J, et al.
Publicado: (2012)

The Australian Ovarian Cancer Study
por: Traficante, N, et al.
Publicado: (2012)

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
por: Cooke, Susanna L, et al.
Publicado: (2010)

Expression signatures of TP53 mutations in serous ovarian cancers
por: Bernardini, Marcus Q, et al.
Publicado: (2010)

Psammocarcinoma of ovary with serous cystadenofibroma of contralateral ovary: a case report
por: Jain, Deepali, et al.
Publicado: (2009)

Bilateral Serous Psammocarcinoma of Ovary: Rare Variant Low Grade Serous Carcinoma
por: Jena, Saubhagya Kumar, et al.
Publicado: (2015)

Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer
por: Etemadmoghadam, Dariush, et al.
Publicado: (2010)

Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer
por: Nath, Aritro, et al.
Publicado: (2021)

Oncogenes in high grade serous adenocarcinoma of the ovary
por: Manasa, Pacharla, et al.
Publicado: (2020)

Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan
por: Chou, Hung-Hsueh, et al.
Publicado: (2022)

Malignant degeneration of mature cystic teratoma of the ovary with small bowel metastasis incidental serous cystadenoma collision tumor of the right ovary
por: Abduljabbar, Ahmed, et al.
Publicado: (2021)

The Continuum of Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary
por: Wong, Kwong-Kwok, et al.
Publicado: (2007)

CT features of low grade serous carcinoma of the ovary
por: Pannu, Harpreet K.
Publicado: (2015)

Educational Case: High-Grade Serous Carcinoma of the Ovary
por: Bunde, Sophia, et al.
Publicado: (2021)

Low-Grade Serous Carcinoma of the Ovary: The Current Status
por: Babaier, Abdulaziz, et al.
Publicado: (2022)

Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt
por: Ahmed, Ahmed Ashour, et al.
Publicado: (2005)

Hepatic resection of metastatic tumor from serous cystadenocarcinoma of the ovary.
por: Lee, Jong Hoon, et al.
Publicado: (2002)

Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers
por: Tuna, Musaffe, et al.
Publicado: (2019)

Ancient ubiquitous protein 1 (AUP1) is a prognostic biomarker connected with TP53 mutation and the inflamed microenvironments in glioma
por: Chang, Pei-Chi, et al.
Publicado: (2023)

Differential expression of selected histone modifier genes in human solid cancers
por: Özdağ, Hilal, et al.
Publicado: (2006)

The ubiquitous quasidisk
por: Gehring, Frederick W, et al.
Publicado: (2012)

Ubiquitous Amyloids
por: Pulawski, Wojciech, et al.
Publicado: (2012)

Imaging of serous psammomacarcinoma of ovary with subcutaneous deposits: A case report
por: Diwakar, Nagaraj, et al.
Publicado: (2011)

Cerebellar metastasis from serous adenocarcinoma of the ovary mimicking pilocytic astrocytoma
por: Tandon, Vivek, et al.
Publicado: (2012)

Fatal cardiac tamponade following cytoreductive surgery for serous carcinoma of the ovary
por: English, Emily, et al.
Publicado: (2015)

Cytology of peritoneal implants of borderline serous tumor of ovaries in ascitic fluid
por: Sharma, Sudha, et al.
Publicado: (2021)

Mutational Analysis of KRAS, BRAF, and TP53 Genes of Ovarian Serous Carcinomas in Korean Women
por: Cho, Yun-Hyun, et al.
Publicado: (2009)

Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression
por: Mota, Alba, et al.
Publicado: (2015)

No evidence for PALB2 methylation in high-grade serous ovarian cancer
por: Mikeska, Thomas, et al.
Publicado: (2013)

Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary
por: Posner, Atara, et al.
Publicado: (2023)

Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
por: Schwarz, Roland F., et al.
Publicado: (2015)

Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary.
por: Orre, M., et al.
Publicado: (1998)

High Throughput Interrogation of Somatic Mutations in High Grade Serous Cancer of the Ovary
por: Matulonis, Ursula A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hlbnojk47o35btfek2eomu5iv2